Next-generation brain proteomics: Integrating single-cell, spatial, and multi-omics for clinical biomarker discovery.
The clinical translational trajectory is delineated, illustrating how aberrant signatures are verified in cerebrospinal fluid and validated in plasma to support precision medicine and arguing for the necessity of "fused" multi-omics integration and Artificial Intelligence to decode the non-linear molecular logic of brain pathology.